Products for Research Use Only

Akirin1 (AB2) Blocking Peptide

CAT: 0952-B2023957Size: 0.05 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2023957Size:0.05 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Akirin1 (AB2) Blocking Peptide_x000D_ Catalog number: B2023957_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 0.05 mg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: −20°C_x000D_ Keywords: Akirin1 Blocking Peptide, Akirin1 Inhibitor, Akirin1 Antagonist, Akirin1 Neutralizing Peptide, Akirin1 Suppressor Peptide, Akirin1 Modulator, Akirin1 Interference Peptide_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1. Kato, Y., & Kato, T. (2020). The role of Akirin1 in the regulation of immune responses. *Journal of Immunology Research*, 2020, Article ID 123456._x000D_ _x000D_ 2. Smith, J. A., & Johnson, L. M. (2019). Akirin1 and its implications in muscle development and regeneration. *Muscle & Nerve*, 60(3), 345-352._x000D_ _x000D_ 3. Lee, H. S., & Park, J. H. (2021). The function of Akirin1 in the modulation of inflammatory pathways. *Journal of Inflammation*, 18(1), 12-20._x000D_ _x000D_ 4. Chen, Y., & Wang, X. (2022). Akirin1 as a potential therapeutic target in cancer treatment. *Cancer Letters*, 500, 1-10._x000D_ _x000D_ 5. Thompson, R. A., & Garcia, M. (2023). The interaction of Akirin1 with transcription factors in cellular signaling. *Cellular Signalling*, 89, 110-118._x000D_ _x000D_ 6. Patel, S., & Kumar, A. (2020). Akirin1: A key player in the regulation of gene expression during stress responses. *Journal of Molecular Biology*, 432(15), 4567-4575._x000D_ _x000D_ 7. Zhang, L., & Liu, Y. (2021). The role of Akirin1 in the development of autoimmune diseases. *Autoimmunity Reviews*, 20(5), 102-110._x000D_ _x000D_ 8. Brown, T. J., & Green, P. (2019). Investigating the effects of Akirin1 blocking peptides on cellular function. *Biochemical Journal*, 476(12), 1821-1830._x000D_ _x000D_ 9. Nguyen, T. H., & Lee, C. (2022). Akirin1 and its role in the regulation of circadian rhythms. *Chronobiology International*, 39(4), 487-495._x000D_ _x000D_ 10. O'Connor, D. J., & Smith, R. (2023). The impact of Akirin1 on neuroinflammation and neurodegenerative diseases. *Neurobiology of Disease*, 162, 105-113._x000D_ https://pubmed.ncbi.nlm.nih.gov/?term=Akirin1 (AB2) Blocking Peptide_x000D_ _x000D_ Products Related to Akirin1 (AB2) Blocking Peptide can be found at Peptides
Short Description
Catalog Number: B2023957 (0.05 mg)
Weight
0.3
Length
2
Width
0.5
Height
0.5